300548SZSE

Changxin博创 Technology Co., Ltd. Announcement on Adjusting the 2026 Annual Routine Related Transaction Quota

EverProX Technologies Co., Ltd.··4 pages

✨ AI Summary

Changxin博创 Technology Co., Ltd. is adjusting its 2026 annual routine related transaction quota with Changfei Optical Fiber and Cable Co., Ltd. The quota is increased by RMB 1.52 billion to a total of RMB 2 billion, primarily for raw material procurement and product sales. The adjustment was approved by the board and will be submitted for shareholder approval.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Changxin博创 Technology Co., Ltd. Announcement on Adjusting the 2026 Annual Routine Related Transaction Quota

The company and the entire board of directors guarantee that the content of this information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

I. Basic Situation of Related Transactions

  1. Overview of Routine Related Transactions

Changxin博创 Technology Co., Ltd. (hereinafter referred to as the "Company") and its subsidiaries, based on the needs of actual business development, estimate that the routine related transactions with Changfei Optical Fiber and Cable Co., Ltd. (hereinafter referred to as "Changfei Optical Fiber") and its subsidiaries, jointly invested companies, and associated enterprises in 2026 will increase by RMB 1.52 billion. The adjusted total amount will not exceed RMB 2 billion. The main content of the related transactions includes the procurement of raw materials and the sale of goods.

On December 12, 2025, the Company held the 23rd meeting of the Sixth Board of Directors and the 21st meeting of the Sixth Supervisory Board, and deliberated and approved the "Proposal on the Estimated Quota of Routine Related Transactions for 2026". Related directors Zhuang Dan, Peter Johannes Wijnandus Marie Bongaerts, Zhou Lijing, Zheng Xin, and Luo Jie, and related supervisor Jinpei Yang, abstained from voting. Before being submitted to the Board of Directors for deliberation, this related transaction had been reviewed and approved by the independent directors' special committee. On December 29, 2025, the Company held its fourth extraordinary general meeting of shareholders in 2025 and deliberated and approved the "Proposal on the Estimated Quota of Routine Related Transactions for 2026".

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.